BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Nordic Nanovector: Notice of Extraordinary General Meeting

  The Board of Directors of Nordic Nanovector call for an Extraordinary General Meeting to be held at Thon Hotel Vika Atrium, Munkedamsveien 45, Oslo on 20 December 2017 at 10:30 CET.

  November 29, 2017

   · 

  2 min read
• Business

  BIOCORP Signs Strategic Partnership for NewGuard With Global Leader in Heparin Market

  This partnership will enable the partner group to integrate and commercialize the NewGuard safety device, developed by BIOCORP, in the field of pre-filled syringes and more specifically on the heparin segment, an immediate-acting anticoagulant of which it is the 2nd th world player.

  November 29, 2017

   · 

  3 min read
• Biotech Beach

  Navigate Cardiac Structures Reports “Exceptional” Six-Week Results for Two Implantations of its GATE Atrioventricular Valved Stent to Correct Severe Tricuspid Regurgitation Patients at New York-Presbyterian/Columbia University Hospital

  In both cases, implantation of the GATE™ AVS resulted in correction of tricuspid regurgitation and restoration of normal valvular function.

  November 29, 2017

   · 

  4 min read
• Ablynx: Publication In Accordance With Article 14 Of The Belgian Law Of 2 May 2007 Regarding The Publication Of Major Shareholdings (The “Transparency Law”) – Nov. 29, 2017

  Millennium Group Management LLC notified Ablynx that it has crossed downward the lowest threshold on 21 November 2017.

  November 29, 2017

   · 

  4 min read
• VANC Pharmaceuticals Closes Oversubscribed Private Placement

  The company has closed an oversubscribed non-brokered private placement for a total of 4,850,000 units (the “Units”) of the Company at a price of $0.15 per Unit for gross proceeds of approximately CDN$727,500.00.

  November 29, 2017

   · 

  4 min read
• Biotech Bay

  Updated TCAR Data From Silk Road Medical’s ROADSTER 1 and 2 Studies Presented at VEITHsymposium

  The data from this year’s VEITHsymposium add to the body of evidence supporting the use of Silk Road Medical’s ENROUTE system.

  November 29, 2017

   · 

  4 min read
• Biotech Beach

  Cytori Closes Rights Offering for Gross Proceeds of $10M

  The warrants will be exercisable upon stockholder approval to increase our authorized shares of common stock.

  November 29, 2017

   · 

  2 min read
• Drug Development

  Ovid Therapeutics Announces OV101 Shows Comparable PK Profile in Phase 1 Study of Adolescent Patients and Amends Phase II STARS Clinical Trial Protocol to Include Adolescents

  The Company will now include adolescent patients aged 13 years and older in the Phase 2 STARS trial.

  November 29, 2017

   · 

  9 min read
• Business

  Lannett Announces Agreement for Authorized Generic Version of Toprol-XL

  Lannett today announced that it has entered into an agreement with Aralez Pharmaceuticals Trading DAC to become the exclusive distributor in the U.S. of the authorized generic version of Toprol-XL Extended Release Tablets in 25 mg, 50 mg, 100 mg and 200mg.

  November 29, 2017

   · 

  2 min read
• Pharm Country

  Bristol-Myers Squibb to Present New Data Across a Broad Range of Blood Cancers at the 59th Annual Meeting & Exposition of the American Society of Hematology

  Presentations across tumor types, including Hodgkin and non-Hodgkin lymphomas, leukemia and multiple myeloma, reinforce Bristol-Myers Squibb’s deep expertise in hematologic cancers and commitment to advancing science to improve patient outcomes.

  November 29, 2017

   · 

  48 min read